Activin and Inhibin

Debio 0932 (CUDC-305) is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectivelyIn VitroDebio 0932 is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectively.

Debio 0932 (CUDC-305) is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectivelyIn VitroDebio 0932 is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectively.

Debio 0932 (CUDC-305) is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectivelyIn VitroDebio 0932 is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectively.

Debio 0932 (CUDC-305) is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectivelyIn VitroDebio 0932 is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectively.

Debio 0932 (CUDC-305) is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectivelyIn VitroDebio 0932 is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectively.

Debio 0932 (CUDC-305) is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectivelyIn VitroDebio 0932 is an orally active HSP90 inhibitor, with IC 50 s of 100 and 103 nM for HSP90α and HSP90β, respectively.

Debutyldronedarone (SR35021) hydrochloride, the main metabolite of Dronedarone, is a selective thyroid hormone receptor α 1 ( TRα 1 ) inhibitor. Debutyldronedarone hydrochloride inhibits T3 binding to TRα 1 and TRβ 1 by 77% and 25%, respectively.

Debutyldronedarone (SR35021) hydrochloride, the main metabolite of Dronedarone, is a selective thyroid hormone receptor α 1 ( TRα 1 ) inhibitor. Debutyldronedarone hydrochloride inhibits T3 binding to TRα 1 and TRβ 1 by 77% and 25%, respectively.

Debutyldronedarone (SR35021) hydrochloride, the main metabolite of Dronedarone, is a selective thyroid hormone receptor α 1 ( TRα 1 ) inhibitor. Debutyldronedarone hydrochloride inhibits T3 binding to TRα 1 and TRβ 1 by 77% and 25%, respectively.

Debutyldronedarone (SR35021) hydrochloride, the main metabolite of Dronedarone, is a selective thyroid hormone receptor α 1 ( TRα 1 ) inhibitor. Debutyldronedarone hydrochloride inhibits T3 binding to TRα 1 and TRβ 1 by 77% and 25%, respectively.

Decloxizine dihydrochloride(UCB-1402: NSC289116) is a histamine 1 receptor antagonist.Form:SolidIC50&amp: Target:H 1 Receptor.

Decloxizine dihydrochloride(UCB-1402: NSC289116) is a histamine 1 receptor antagonist.Form:SolidIC50&amp: Target:H 1 Receptor.